Rifabutin
- TRADE NAME: Mycobutin (Pfizer)
- INDICATIONS: Disseminated Mycobacterium avium infection
- CLASS: Antibiotic, Antibiotic; rifamycin, Antimicrobial, CYP3A4 inducer
- HALF-LIFE: 45 hours
Abiraterone, Amiodarone, Amprenavir, Anisindione, Anticoagulants, Atazanavir, Atovaquone, Atovaquone/Proguanil, Azithromycin, Bedaquiline, Bictegravir/Emtricitabine/Tenofovir Alafenamide, Boceprevir, Cabazitaxel, Cabozantinib, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Alafenamide, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxil, Corticosteroids, Crizotinib, Cyclosporine, Dapsone, Darunavir, Delavirdine, Dicumarol, Doravirine, Doravirine/Lamiduvine/Tenofovir Disoproxil, Efavirenz, Enzalutamide, Erlotinib, Etravirine, Flibanserin, Fosamprenavir, Indinavir, Itraconazole, Ixabepilone, Lapatinib, Ledipasvir & Sofosbuvir, Levonorgestrel, Lopinavir, Midazolam, Mifepristone, Nelfinavir, Oral Contraceptives, Posaconazole, Rilpivirine, Ritonavir, Romidepsin, Simeprevir, Sofosbuvir, Sofosbuvir & Velpatasvir, Sofosbuvir/Velpatasvir/Voxilaprevir, Solifenacin, Sonidegib, Sorafenib, Sunitinib, Tacrolimus, Temsirolimus, Tenofovir Alafenamide, Tezacaftor/Ivacaftor, Thalidomide, Tipranavir, Tolvaptan, Vandetanib, Vemurafenib, Voriconazole
PREGNANCY CATEGORY: B
Please login to see the rest of this drug profile
Page last updated 08/01/2022
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
